A prospective observational study of Induced Pluripoteint Stem Cell-derived Cardiac Spheres transplantation EXTENDed Follow-up

A prospective observational study of Induced Pluripoteint Stem Cell-derived Cardiac Spheres transplantation EXTENDed Follow-up - IPSCS-EXTEND study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047335

Enrollment

Registered

2022-04-01

Start date

2022-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects of the safety study of regenerative therapy with allogeneic induced pluripotent stem cell-derived cardiac spheres for severe heart failure (jRCTa032200189) approved by the Specified Certified Regenerative Medicine Committee.

Exclusion criteria

Exclusion criteria: Patients that do not meet the selection criteria.

Design outcomes

Primary

Measure	Time frame
Long-term safety of iPS cell-derived cardiomyocyte transplantation	—

Secondary

Measure	Time frame
Long-term efficacy of iPS cell-derived cardiomyocyte transplantation	—

Countries

Japan

Contacts

Public ContactYoshikazu Kishino

Keio University School of Medicine Cardiology

ykishino@keio.jp03-5843-6702

Outcome results